bromocriptine has been researched along with dironyl in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A | 1 |
| Bowie, M; Boyar, RM; Budinger, JM; Hellman, L; Mountain, IM; Rosenberg, BJ; Stock, CC; Teller, MN | 1 |
| Al-Sereiti, MR; Turner, P | 1 |
| Rinne, UK | 1 |
| Besser, M; Ciccarelli, E; Grossman, A; Touzel, R | 1 |
| Chiodini, PG; Dallabonzana, D; Dorow, R; Horowski, R; Liuzzi, A; Oppizzi, G; Verde, G | 1 |
| Cvak, L; Golda, V | 1 |
| Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M | 1 |
| Kokunai, T; Tamaki, N; Yonezawa, K | 1 |
| Ichihara, K; Kamei, H; Mizukoshi, K; Nagasaka, M; Okumura, K | 1 |
| Asano, S; Kirino, T; Suzuki, I; Ueki, K | 1 |
| Ishiguro, T; Iwai, Y; Komiyama, M; Matsuzaka, Y; Morikawa, T; Yamanaka, K; Yasui, T | 1 |
| Hashimoto, S; Midorikawa, S; Sanada, H; Watanabe, T; Yatabe, J | 1 |
1 review(s) available for bromocriptine and dironyl
| Article | Year |
|---|---|
Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetonitriles; Androstanols; Animals; Breast Neoplasms; Bromocriptine; Drug Evaluation, Preclinical; Ergolines; Ergot Alkaloids; Estradiol; Female; Humans; Lisuride; Mammary Neoplasms, Experimental; Prolactin; Rats; Urea | 1977 |
2 trial(s) available for bromocriptine and dironyl
| Article | Year |
|---|---|
The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
Topics: Adult; Bromocriptine; Double-Blind Method; Ergolines; Humans; Intraocular Pressure; Lisuride; Random Allocation | 1989 |
Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
Topics: Adult; Blood Pressure; Bromocriptine; Double-Blind Method; Drug Evaluation; Ergolines; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Lisuride; Male; Prolactin; Pulse; Random Allocation; Thyrotropin | 1988 |
10 other study(ies) available for bromocriptine and dironyl
| Article | Year |
|---|---|
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin | 2002 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
Topics: Acromegaly; Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Prolactin; Time Factors | 1985 |
Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
Topics: Animals; Blood Pressure; Body Weight; Bromocriptine; Disease Models, Animal; Female; Glucose Intolerance; Hyperlipidemias; Hypertension; Insulin; Lipids; Lisuride; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors | 1994 |
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting | 1993 |
Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat.
Topics: Animals; Apoptosis; Bromocriptine; Cell Division; Cell Migration Inhibition; Dopamine Agonists; Estradiol; Female; Hormone Antagonists; Lisuride; Neoplastic Cells, Circulating; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar | 1997 |
Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Lisuride; Male; Rats; Rats, Wistar; Reserpine; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics | 1998 |
Clinical features and medical treatment of male prolactinomas.
Topics: Adult; Bromocriptine; Decompression, Surgical; Dopamine Agonists; Hormone Antagonists; Humans; Libido; Lisuride; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome; Visual Fields | 2001 |
[Results of treatment for male prolactinomas].
Topics: Adult; Bromocriptine; Dopamine Agonists; Humans; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Prolactinoma | 2002 |
Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma.
Topics: Acanthosis Nigricans; Acromegaly; Adenoma; Adult; Bromocriptine; Dopamine Agents; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lisuride; Magnetic Resonance Imaging; Menstrual Cycle; Ovary; Pancreatic Function Tests; Pituitary Function Tests; Pituitary Neoplasms; Polycystic Ovary Syndrome; Theca Cells | 2003 |